<DOC>
	<DOCNO>NCT01789333</DOCNO>
	<brief_summary>The purpose study see bright light allow shorten treatment time require stabilize eye patient keratoconus bulge cornea . The investigator compare therapeutic effect two different high brightness ultra violet light riboflavin treat eye . One light twice bright exposure time brighter light deliver equivalent energy cornea reduce standard 30 minute 10 5 minute . Riboflavin vitamin B2 investigator try determine identical clinical effect achieve brighter treatment light use short time . The investigator also monitor clinical effect status cornea see additional risk associate brighter light .</brief_summary>
	<brief_title>Higher Irradiance Keratoconus Ectasia</brief_title>
	<detailed_description />
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects one eye meet two follow criterion consider candidate study : 1 . 18 year age old 2 . Having diagnosis progressive keratoconus pellucid marginal degeneration . 1 . Characteristic pattern deformity analyze Pentacam map . 2 . Minimal thickness 350 micron 3 . Signed write informed consent 4 . Willingness ability comply schedule followup visit 5 . Contact lens removal prior evaluation treatment Inclusion criterion ectasia 1 . History undergone keratorefractive procedure : 1 . Steepening topography , either Pentacam Humphrey 2 . Thinning cornea 3 . Shift position thin portion cornea 4 . Unstable refraction increase myopia astigmatism 5 . Development irregular astigmatism 2 . At least two criterion must present . Subjects meet follow criterion exclude study : 1 . Eyes classify either normal , atypical normal , 2 . Corneal pachymetry â‰¤ 350 micron thinnest point measure Pentacam . 3 . A history chemical injury delay epithelial healing . 4 . Pregnancy ( include plan become pregnant ) lactation course study 5 . A known sensitivity study medication 6 . Patients nystagmus condition would prevent steady gaze treatment 7 . Inability cooperate diagnostic test . 8 . Patients current condition , investigator 's opinion , would interfere prolong epithelial healing . 9 . Taking Vitamin C ( ascorbic acid ) supplement within 1 week crosslinking treatment . 10 . Patients unable remain supine tolerate lid speculum .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Keratoconus</keyword>
	<keyword>Ectasia</keyword>
	<keyword>UVA light</keyword>
	<keyword>riboflavin</keyword>
	<keyword>post-LASIK</keyword>
	<keyword>irregular astigmatism</keyword>
</DOC>